Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand

International Journal of Rheumatic Diseases

Volumn 14, Issue 3, 2011, Pages 282-289

  Foocharoen, Chingching ^a   Nanagara, Ratanavadee ^a   Kiatchoosakun, Songsak ^a   Suwannaroj, Siraphop ^a   Mahakkanukrauh, Ajanee ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Mortality rate; Prognosis; Pulmonary arterial hypertension; Pulmonary fibrosis; Pulmonary hypertension; Scleroderma; Survival rate; Systemic sclerosis

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; ASPIRATION PNEUMONIA; CAUSE OF DEATH; COMORBIDITY; DISEASE SEVERITY; ESOPHAGUS DISEASE; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOSITIS; PERICARDITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PULMONARY HYPERTENSION; SURVIVAL; SURVIVAL RATE; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; THAILAND; WORLD HEALTH ORGANIZATION;

ADULT; AGED; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SCLERODERMA, SYSTEMIC; SURVIVAL RATE; THAILAND; TIME FACTORS;

EID: 79961172641     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2011.01625.x     Document Type: Article

References (37)

1. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, et al. (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48, 2246-55.
2. Pope JE, Lee P, Baron M, et al. (2005) Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. J Rheumatol 32, 1273-8.
3. Silman AJ (1997) Scleroderma-demographics and survival. J Rheumatol Suppl 48, 58-61.
4. Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA Jr (1997) Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 40, 441-5.
5. Yousem SA (1990) The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol 21, 467-74.
6. Rosenkranz S (2007) Pulmonary hypertension: current diagnosis and treatment. Clin Res Cardiol 96, 527-41.
7. Sallach SM, Peshock RM, Reimold S (2007) Noninvasive cardiac imaging in pulmonary hypertension. Cardiol Rev 15, 97-101.
8. Galie N, Torbicki A, Barst R, et al. (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25, 2243-78.
9. Penning S, Robinson KD, Major CA, Garite TJ (2001) A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension. Am J Obstet Gynecol 184, 1568-70.
10. Bossone E, Avelar E, Bach DS, Gillespie B, Rubenfire M, Armstrong WF (2000) Diagnostic value of resting tricuspid regurgitation velocity and right ventricular ejection flow parameters for the detection of exercise induced pulmonary arterial hypertension. Int J Card Imaging 16, 429-36.
11. Denton CP, Cailes JB, Phillips GD, Wells AU, Black CM, Bois RM (1997) Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 36, 239-43.
12. Dellegrottaglie S, Sanz J, Poon M, et al. (2007) Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology 243, 63-9.
13. Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA Jr (1986) Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 29, 515-24.
14. MacGregor AJ, Canavan R, Knight C, et al. (2001) Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology (Oxford) 40, 453-9.
15. Yamane K, Ihn H, Asano Y, et al. (2000) Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology (Oxford) 39, 1269-71.
16. Koh ET, Lee P, Gladman DD, Abu-Shakra M (1996) Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 35, 989-93.
17. Ungerer RG, Tashkin DP, Furst D, et al. (1983) Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 75, 65-74.
18. Siebold JR (2005) Scleroderma. In: Harris ED Jr, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB (eds) Kelley's Textbook of Rheumatology, 7th edn, pp 1279-308. Elsevier Saunders, USA.
19. Trad S, Amoura Z, Beigelman C, et al. (2006) Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum 54, 184-91.
20. Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE (2003) Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 123, 344-50.
21. Simeon CP, Armadans L, Fonollosa V, et al. (1997) Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis. Ann Rheum Dis 56, 723-8.
22. Mukerjee D, St George D, Coleiro B, et al. (2003) Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 62, 1088-93.
23. Wangkaew SKN, Phrommintikul A, Sukitawut W, Wichainun R, Louthrenoo W (2008) Pulmonary arterial hypertension in Thai patients with systemic sclerosis. J Med Assoc Thai 91, 166-72.
24. Kiatchoosakun S, Ungkasekvinai W, Wonvipaporn C, Tatsanavivat P, Foocharoen C, Suwannaroj S, Nanagara R (2007) D-dimer and pulmonary arterial hypertension in systemic sclerosis. J Med Assoc Thai 90, 2024-9. [Correction added after online publication 22 July: The original reference was replaced with "Kiatchoosakun S, Ungkasekvinai W, Wonvipaporn C, Tatsanavivat P, Foocharoen C, Suwannaroj S, Nanagara R (2007) D-dimer and pulmonary arterial hypertension in systemic sclerosis. J Med Assoc Thai90, 2024-9."].
25. Kasukawa R, Nishimaki T, Takagi T, Miyawaki S, Yokohari R, Tsunematsu T (1990) Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study. Clin Rheumatol 9, 56-62.
26. Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23, 581-90.
27. Barst RJ, McGoon M, Torbicki A, et al. (2004) Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S), 40S-7S.
28. Denis P, Ducrotte P, Pasquis P, Lefrancois R (1981) Esophageal motility and pulmonary function in progressive systemic sclerosis. Respiration 42, 21-4.
29. Ioannou Y, Sultan S, Isenberg DA (1999) Myositis overlap syndromes. Curr Opin Rheumatol 11, 468-74.
30. West SG, Killian PJ, Lawless OJ (1981) Association of myositis and myocarditis in progressive systemic sclerosis. Arthritis Rheum 24, 662-8.
31. Carette S, Turcotte J, Mathon G (1985) Severe myositis and myocarditis in progressive systemic sclerosis. J Rheumatol 12, 997-9.
32. Kerr LD, Spiera H (1993) Myocarditis as a complication in scleroderma patients with myositis. Clin Cardiol 16, 895-9.
33. Jing ZC, Xu XQ, Han ZY, et al. (2007) Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest 132, 373-9.
34. Garin MC, Highland KB, Silver RM, Strange C (2009) Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol 36, 330-6.
35. Johnson SR, Swinton JR, Granton JT (2008) Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension. J Rheumatol 35, 1584-90.
36. Hsiao SH, Lee CY, Chang SM, Lin SK, Liu CP (2006) Right heart function in scleroderma: insights from myocardial Doppler tissue imaging. J Am Soc Echocardiogr 19, 507-14.
37. Currie PJ, Seward JB, Chan KL (1985) Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol 6, 750-6.